Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic
Related posts
-
Two men charged with attempted murder in September attack in Mount Prospect
Two men are facing attempted murder charges following an investigation into the shooting and stabbing of... -
Mount Prospect agreement with feed producer stipulates hours, odor levels
Mount Prospect has released the confidential agreement with Prestige Feed Products, in response to a Freedom... -
$1 million Illinois lottery ticket sold at Elmhurst grocery store
A shopper at an Elmhurst Jewel-Osco grocery store won $1 million last month in the Illinois...